Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Series A leads to $19.3mm for Sera Prognostics

Executive Summary

Sera Prognostics Inc. (diagnostics to predict pregnancy complications) has raised $19.3mm through its Series A venture round. New investors InterWest Partners, Domain Associates, and Catalyst Health Ventures led the financing and will each contribute one board member. They were joined by the company’s founder, UpStart Life Sciences Capital, and new backer Osage University Partners.
Deal Industry
  • Biotechnology
  • In Vitro Diagnostics
  • In Vitro Diagnostics
    • Molecular Diagnostics & Genetic Testing
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies